AMN Healthcare AMN Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by AMN Healthcare in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AMN Healthcare's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AMN Healthcare's cash & equivalents?
- AMN Healthcare (AMN) reported cash & equivalents of $594.98M in Q1 2026.
- How has AMN Healthcare's cash & equivalents changed year-over-year?
- AMN Healthcare's cash & equivalents increased by 528.2% year-over-year, from $94.72M to $594.98M.
- What is the long-term trend for AMN Healthcare's cash & equivalents?
- Over 5 years (2020 to 2025), AMN Healthcare's cash & equivalents has grown at a -4.4% compound annual growth rate (CAGR), from $83.99M to $67.17M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.